Seroquel Long-Term NIS for Schizophrenia Patients

24-Week Naturalistic Observational Study of Efficacy of Quetiapine in Patients With Schizophrenia or Schizoaffective Disorder

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00523783

Acronym

SELECT

Enrollment

1000

Registered

2007-08-31

Start date

2007-05-31

Completion date

2008-05-31

Last updated

2008-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizoaffective Disorder, Schizophrenia

Keywords

Schizophrenia, Schizoaffective, quetiapine, long-term efficacy, Naturalistic, Observational

Brief summary

To assess the efficacy of 24-week treatment with quetiapine in patients with schizophrenia or schizoaffective disorder

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* The patient and the patient's legal representative (if any) must understand the nature of the study and must have given written consent * The patient suffers from schizophrenia or schizoaffective disorder according to DSM-IV-TR * The patient is between 18 and 65 years old(extremes included) * On the basis of physical and neurological examination, medical history, the patient is, in the investigator's opinion, otherwise healthy * If the subject is a female of childbearing potential, she must be not pregnant or breast-feeding and be using a reliable method of contraception. Reliable methods may include abstinence, hormonal contraceptives (eg,oral contraceptives or long-term injectable or implantable hormonal contraceptives), double-barrier methods (eg, condom and diaphragm, condom and foam, condom and sponge), intrauterine devices, and tubal ligation

Exclusion criteria

* The patients who have known hypersensitivity to quetiapine

Countries

South Korea

Outcome results